Pancreatic Cancer Research

ResearcherChinese University of Hong KongNo recent work listed

Jin-Ling Tang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0536-0083; OpenAlex author ID A5102887243. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper

Papers 2

  1. Predictive role of skin rash in advanced pancreatic cancer patients treated with gemcitabine plus erlotinib: a systematic review and meta-analysis. Last author DOI 10.2147/ott.s168418↗
  2. Gemcitabine plus erlotinib for advanced pancreatic cancer: a systematic review with meta-analysis. Last author DOI 10.1371/journal.pone.0057528↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zu‐Yao Yang · 2 shared papers, 2013–2018 · strength 0.13
  2. Minyan Zeng · 1 shared paper, 2018 · strength 0.10
  3. Jun Zhou · 1 shared paper, 2018 · strength 0.10
  4. Jinqiu Yuan · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.